88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

Next page >

Mabwell's 9MW5211 Receives IND Clearance from NMPA for Inflammatory Bowel Disease SHANGHAI , June 5, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its independently developed ... 2026-06-05T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility SINGAPORE , June 5, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has completed the topping ... 2026-06-05T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Osara Health Expands Into Survivorship Care, Strengthening Cancer Support Beyond Treatment The expanded Cancer Coach program introduces new survivorship modules building on the latest outcomes showing a 25:1 ROI and ~66% of participants improved physical and mental health. ... 2026-06-05T Health Care/Hospital Medical/Pharmaceuticals
Optellum Celebrates Accelerating Impact in Lung Cancer Care; Now at Over 250 Sites and Growing OXFORD, United Kingdom and HOUSTON , June 5, 2026 /PRNewswire/ -- Optellum , a leader in AI-enabled lung cancer diagnostics, today announced that it has surpassed 250 clinical sites and analyzed more ... 2026-06-05T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Global Ergothioneine Market Poised for Accelerated Growth as Scientific Validation and Synthetic Biology Reshape Industry Dynamics New Frost & Sullivan White Paper Highlights Emerging Opportunities Across Healthy Aging, Functional Nutrition, Personal Care, and Preventive Healthcare ... 2026-06-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Stronger Together, Shaping the Future \| WuXi XDC and BioDlink Successfully Concluded 2026 Open Day WuXi XDC and BioDlink jointly hosted the 2026 Open Day, marking their first flagship customer-facing event following the strategic integration. The event brought together biotech customers, industry ... 2026-06-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
PharmaBlock's First Peptide GMP Pilot-scale Plant at PharmaBlock Zhejiang Site Now Operational Next-Generation Peptide CRDMO Solutions Enabled by a Green and Intelligent Platform for Empowering Global Innovative Drug Development ... 2026-06-04T Chemical Health Care/Hospital Medical/Pharmaceuticals
Innovative Drug Update \| Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10 SHENZHEN, China , June 4, 2026 /PRNewswire/ -- Recently, the first subject was enrolled and dosed in the Phase I clinical trial in China for GB10 Injection, an innovative ophthalmic drug independently ... 2026-06-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin® in the Asia-Pacific Market Everest Medicines has obtained exclusive rights for the clinical development and commercialization of Bejescin ® (MIL62, Obinutuzumab beta Injection) across the Asia-Pacific region, including Southeast ... 2026-06-04T Health Care/Hospital Medical/Pharmaceuticals
World's First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory Gastric Cancer and NDA Accepted by China NMPA SAN FRANCISCO and SUZHOU, China , June 4, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ... 2026-06-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved